Timothy Springer
$1.0B
Born
Feb 23, 1948
Age
77
Source of Wealth
Biotech
Residence
Chestnut Hill, Massachusetts
Citizenship
United States
Marital Status
Married
Children
0
Education
Ph.D, Harvard University; Bachelor of Science, University of California, Berkeley
- Timothy Springer is an immunologist and professor of biological chemistry and molecular pharmacology at Harvard Medical School.
- He was a founding investor in publicly traded biotech outfit Moderna in 2010, investing about $5 million; he now owns 2.7% of the firm's shares.
- Springer also owns shares in three smaller publicly traded biotech firms: Cartesian Therapeutics, Scholar Rock and Morphic Therapeutic.
- He first started teaching at Harvard in 1977 as an assistant professor.
- In 1993, he founded biotech firm LeukoSite and took it public in 1998; the next year, he sold it to Millennium Therapeutics for $635 million.
- In 2017, Springer established the Institute for Protein Innovation, an independent nonprofit focused on researching proteins, with an initial grant of $10 million.
- Springer bikes to work from his home in Chestnut Hill, Massachusetts.
| Exchange | Ticker | Company Name | Number Of Shares | Share Price | Currency Code |
|---|